Prof. Nikolaos Korfiatis
Open Menu
Close Menu
Research
Publications
Clinical Trials
News
Teaching
Supervision
Press
ESC
All Results
Searching...
No results found
Clear search
↑↓
Navigate
↵
Select
Powered by Hugo Blox
A. Psyrri
Journal Article
SNF-CLIMEDIN: A Randomized Trial of Digital Support and Intervention in Patients With Advanced Non–Small Cell Lung Cancer. A Hellenic Cooperative Oncology Group Study
p.a.-kosmidis
•
2026
•
1 min read
Read more
Journal Article
Profiling of 1491 tumors from four HeCOG early breast cancer (eBC) studies using targeted DNA sequencing and central pathology review
k.-papadopoulou
•
2026
•
1 min read
Read more
Journal Article
Phase Ib-II Study of Ramucirumab Combined with Nab-paclitaxel and Gemcitabine as First-line Treatment in Patients With Advanced Pancreatic Adenocarcinoma (RACING)
g.-papaxoinis
•
2026
•
1 min read
Read more
Journal Article
Clinico-pathological and genomic features of HER2-low early Breast Cancer (eBC). Results of retrospective analysis of seven adjuvant trials by the Hellenic Cooperative Oncology Group (HeCOG)
s.-lakis
•
2026
•
1 min read
Read more
Journal Article
Brain as a site of first recurrence after adjuvant therapy for early breast cancer: Mining the Hellenic Cooperative Oncology Group database. The BRACE study
e.d.-razis
•
2026
•
1 min read
Read more
Journal Article
SNF-CLIMEDIN: A HECOG prospective randomized trial of digital support and intervention in patients with advanced NSCLC—Final results
p.a.-kosmidis
•
2025
•
1 min read
Read more
Journal Article
Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung cancer (PAVE): Final outcome, immunophenotypic and biomarker analysis of a multi-center phase II Hellenic Cooperative Oncology Group study
h.-linardou
•
2025
•
1 min read
Read more
Journal Article
Frequency of Adverse Events Reported Digitally by Patients with Advanced NSCLC: Analysis From CLIMEDIN, a HeCOG Study
p.-kosmidis
•
2025
•
1 min read
Read more
Conference Paper
Clinico-pathological and genomic features of HER2-low early Breast Cancer (eBC). Results of retrospective analysis of seven adjuvant trials by the Hellenic Cooperative Oncology Group (HeCOG)
s.-lakis
•
2025
•
1 min read
Read more
Journal Article
Clinical outcomes and important prognostic biomarkers following dose-dense sequential adjuvant chemotherapy (dds-CT) in early breast cancer (eBC): Pooled-analysis of individual patient data
a.-goussia
•
2025
•
1 min read
Read more
Next »